An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Ventas Declares Third Quarter 2022 Dividend of $0.45 per Common Share
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per share, payable on October 14, 2022, to stockholders recorded by the close of business on October 3, 2022.
As a leading real estate investment trust, Ventas operates in healthcare and real estate sectors with a portfolio of over 1,200 properties across the United States, Canada, and the United Kingdom. The company leverages its capital to enhance senior living, life science, and healthcare real estate.
Positive
Quarterly dividend declaration of $0.45 per share, reflecting company's financial stability.
Strong portfolio with over 1,200 properties indicates diversification and robust business model.
Recognized as an industry leader with over 20 years of successful long-term strategy.
Negative
None.
CHICAGO--(BUSINESS WIRE)--
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on October 14, 2022 to stockholders of record as of the close of business on October 3, 2022.
About Ventas
Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.